Skip to main content

ADVERTISEMENT

Melanoma

From the Field
08/20/2021
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and...
08/20/2021
Journal of Clinical Pathways
News
07/16/2020
Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...
Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...
...
07/16/2020
Journal of Clinical Pathways
Online Exclusive
11/01/2019
Acral lentiginous melanoma can be particularly difficult to diagnose in the nail, as it classically presents as a black-brown longitudinal band typical of longitudinal melanonychia. However, these authors note with this case study that...
Acral lentiginous melanoma can be particularly difficult to diagnose in the nail, as it classically presents as a black-brown longitudinal band typical of longitudinal melanonychia. However, these authors note with this case study that...
Acral lentiginous melanoma can...
11/01/2019
Podiatry Today
Case Report
10/04/2019
CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...
CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...
CASE REPORT Nodular...
10/04/2019
ePlasty
Case Report and Brief Review
02/06/2019
The authors present the case of a 68-year old man who smokes with a history of hypertension, diabetes, and dyslipidemia, who was referred to the vascular clinic with complaints of intermittent claudication and a developing ulcer on his heel.
The authors present the case of a 68-year old man who smokes with a history of hypertension, diabetes, and dyslipidemia, who was referred to the vascular clinic with complaints of intermittent claudication and a developing ulcer on his heel.
The authors present the case of...
02/06/2019
Wounds
News
09/09/2018
Yttrium-90 (90Y) transarterial radioembolization (TARE) around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival (hPFS) and overall survival (OS) in patients with hepatic metastases...
Yttrium-90 (90Y) transarterial radioembolization (TARE) around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival (hPFS) and overall survival (OS) in patients with hepatic metastases...
Yttrium-90 (90Y) transarterial...
09/09/2018
IO Learning
Quiz
11/10/2016
JCP Editors
A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...
A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...
A...
11/10/2016
Journal of Clinical Pathways
Research in Review
11/01/2016
JCP Editors
Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...
Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...
...
11/01/2016
Journal of Clinical Pathways
Research in Review
07/27/2016
JCP Editors
Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...
Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...
...
07/27/2016
Journal of Clinical Pathways